Table of Content

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY USED FOR THE STUDY 16
1.5 MARKET STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY RESEARCH 18
2.1.2 PRIMARY RESEARCH 19
2.2 MARKET ESTIMATION METHODOLOGY 21
2.2.1 REVENUE-BASED MARKET ESTIMATION 22
2.2.2 USAGE PATTERN-BASED MARKET ESTIMATION 22
2.2.3 PRIMARY RESEARCH VALIDATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 RESEARCH ASSUMPTIONS 25
2.5 RESEARCH LIMITATIONS 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 30
4.1 EUROPEAN MAMMOGRAPHY WORKSTATIONS: MARKET OVERVIEW 30
4.2 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY,
2018 VS. 2024 (USD MILLION) 31
4.3 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION,
2018 VS. 2024 (USD MILLION) 32
4.4 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER,
2018 VS. 2024 (USD MILLION) 33
4.5 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET: GEOGRAPHICAL SNAPSHOT 34

5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Increasing burden of breast cancer and rising geriatric population 36
5.2.1.2 Increased market availability of multimodality diagnostic platforms 37
5.2.1.3 Increasing patient awareness about the clinical benefits associated with the early disease diagnosis 37
5.2.2 RESTRAINTS 38
5.2.2.1 High cost of mammography workstations and procedures 38
5.2.3 OPPORTUNITIES 39
5.2.3.1 Integration of AI and cloud-based technologies in medical imaging workflows 39
5.2.4 CHALLENGES 39
5.2.4.1 Stringent regulatory mandates for product commercialization 39
5.2.4.2 Issues related to breast screening programs 40

6 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 41
6.1 INTRODUCTION 42
6.2 MULTIMODALITY MAMMOGRAPHY WORKSTATIONS 43
6.2.1 MULTIMODALITY MAMMOGRAPHY WORKSTATIONS PLAYING A MAJOR ROLE IN INCREASING BREAST CANCER DETECTION RATE 43
6.3 MAMMOGRAPHY (X-RAY) WORKSTATIONS 44
6.3.1 LOWER COST OF SINGLE-MODALITY MAMMOGRAPHY WORKSTATIONS TO DRIVE THEIR DEMAND IN EMERGING EUROPEAN COUNTRIES 44

7 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 46
7.1 INTRODUCTION 47
7.2 DIAGNOSTIC SCREENING 48
7.2.1 MARKET TRANSITION FROM 2D SCREENING TO 3D IMAGING TO DRIVE THE MARKET DEMAND 48
7.3 ADVANCED IMAGING 49
7.3.1 INTEGRATION OF AI & ADVANCED DATA ARCHIVING/SHARING SOLUTIONS TO DRIVE MARKET GROWTH 49
7.4 CLINICAL REVIEW 50
7.4.1 INCREASING PATIENT-CENTRIC REGULATIONS TO DRIVE GREATER WORKSTATION USAGE AMONG RESEARCHERS AND ACADEMIA 50

8 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 52
8.1 INTRODUCTION 53
8.2 HOSPITALS, SURGICAL CLINICS, & DIAGNOSTIC IMAGING CENTERS 54
8.2.1 HIGHER NUMBER OF SCREENING PROCEDURES TO DRIVE THE DEMAND AMONG MAJOR FACILITIES 54
8.3 BREAST CARE CENTERS 55
8.3.1 MARKET DEMAND IS DRIVEN BY THE INCREASED UTILIZATION OF MULTIMODAL DIAGNOSTIC IMAGING 55
8.4 RESEARCHERS & ACADEMIA 56
8.4.1 BUDGETARY LIMITATIONS FACED BY RESEARCHERS TO RESTRAIN THE ADOPTION OF MULTIMODALITY WORKSTATIONS 56
?

9 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY COUNTRY 58
9.1 INTRODUCTION 59
9.2 GERMANY 59
9.2.1 RISING DEMAND FOR IMPROVED BREAST CANCER SCREENING TO PROPEL MARKET GROWTH 59
9.3 UK 62
9.3.1 HIGH BREAST CANCER INCIDENCE RATE IN THE COUNTRY TO DRIVE MARKET GROWTH 62
9.4 FRANCE 64
9.4.1 LACK OF ESTABLISHED QUALITY CONTROL SCREENING PROGRAMS FOR DIGITAL MAMMOGRAPHY TO HAMPER MARKET GROWTH 64
9.5 ITALY 66
9.5.1 INCREASING DEMAND FOR MAMMOGRAPHY WORKSTATIONS IN GOVERNMENT SCREENING PROGRAMS TO DRIVE MARKET GROWTH 66
9.6 SPAIN 68
9.6.1 LIMITED PURCHASING CAPABILITY OF A MAJORITY OF HEALTHCARE PROVIDERS IN THE COUNTRY TO RESTRAIN MARKET GROWTH 68
9.7 REST OF EUROPE 70

10 COMPETITIVE LANDSCAPE 72
10.1 INTRODUCTION 72
10.2 COMPETITIVE LEADERSHIP MAPPING 72
10.2.1 TERMINOLOGY/NOMENCLATURE 72
10.2.1.1 Visionary Leaders 72
10.2.1.2 Innovators 72
10.2.1.3 Dynamic Differentiators 73
10.2.1.4 Emerging Companies 73
10.3 COMPETITIVE SCENARIO (2015-2019) 74
10.4 EUROPEAN MARKET SHARE ANALYSIS, BY TOP 5 PLAYERS (2017) 76

11 COMPANY PROFILES 78
11.1 AGFA GEVAERT NV 78
11.1.1 BUSINESS OVERVIEW 78
11.1.2 PRODUCTS OFFERED 79
11.1.3 RECENT DEVELOPMENTS (2015–2019) 79
11.2 AYCAN MEDICAL SYSTEMS, LLC. 80
11.2.1 BUSINESS OVERVIEW 80
11.2.2 PRODUCTS OFFERED 80
11.3 BARCO NV 81
11.3.1 BUSINESS OVERVIEW 81
11.3.2 PRODUCTS OFFERED 82
11.3.3 RECENT DEVELOPMENTS (2015–2019) 82
?
11.4 BENETEC ADVANCED MEDICAL SYSTEMS 83
11.4.1 BUSINESS OVERVIEW 83
11.4.2 PRODUCTS OFFERED 83
11.5 CARESTREAM HEALTH (A PART OF ONEX CORPORATION) 84
11.5.1 BUSINESS OVERVIEW 84
11.5.2 PRODUCTS OFFERED 85
11.5.3 RECENT DEVELOPMENTS (2015-2019) 85
11.6 EIZO CORPORATION 86
11.6.1 BUSINESS OVERVIEW 86
11.6.2 PRODUCTS OFFERED 87
11.6.3 RECENT DEVELOPMENTS (2015–2019) 87
11.7 ESAOTE 88
11.7.1 BUSINESS OVERVIEW 88
11.7.2 PRODUCTS OFFERED 88
11.8 FUJIFILM HOLDINGS CORPORATION 89
11.8.1 BUSINESS OVERVIEW 89
11.8.2 PRODUCTS OFFERED 90
11.8.3 RECENT DEVELOPMENTS (2015-2019) 90
11.8.4 MNM VIEW 90
11.9 GENERAL ELECTRIC COMPANY 91
11.9.1 BUSINESS OVERVIEW 91
11.9.2 PRODUCTS OFFERED 92
11.9.3 MNM VIEW 92
11.10 HOLOGIC 93
11.10.1 BUSINESS OVERVIEW 93
11.10.2 PRODUCTS OFFERED 94
11.10.3 RECENT DEVELOPMENTS (2015-2018) 94
11.10.4 MNM VIEW 94
11.11 KONINKLIJKE PHILIPS N.V. 95
11.11.1 BUSINESS OVERVIEW 95
11.11.2 PRODUCTS OFFERED 96
11.11.3 MNM VIEW 96
11.12 KONICA MINOLTA, INC. 97
11.12.1 BUSINESS OVERVIEW 97
11.12.2 PRODUCTS OFFERED 98
11.13 PLANMED OY 99
11.13.1 BUSINESS OVERVIEW 99
11.13.2 PRODUCTS OFFERED 99
11.14 SECTRA AB 100
11.14.1 BUSINESS OVERVIEW 100
11.14.2 PRODUCTS OFFERED 101
11.14.3 RECENT DEVELOPMENTS (2015–2019) 101
11.15 SIEMENS AG 102
11.15.1 BUSINESS OVERVIEW 102
11.15.2 PRODUCTS AND SERVICES OFFERED 103
11.15.3 RECENT DEVELOPMENTS (2015–2019) 103
11.15.4 MNM VIEW 103

12 APPENDIX 104
12.1 DISCUSSION GUIDE 104
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 110
12.3 AVAILABLE CUSTOMIZATIONS 112
12.4 RELATED REPORTS 112
12.5 AUTHOR DETAILS 113
?



List of Figures



FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 MAJOR SECONDARY SOURCES 18
FIGURE 3 KEY DATA FROM PRIMARY SOURCES 20
FIGURE 4 BREAKDOWN OF PRIMARIES 20
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 21
FIGURE 6 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET ESTIMATION:
OVERALL METHODOLOGY 23
FIGURE 7 DATA TRIANGULATION METHODOLOGY 24
FIGURE 8 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 2018 VS. 2024 (USD MILLION) 26
FIGURE 9 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 2018 VS. 2024 (USD MILLION) 27
FIGURE 10 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 2018 VS. 2024 28
FIGURE 11 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET: GEOGRAPHICAL SNAPSHOT 29
FIGURE 12 EXPANSION OF GERIATRIC POPULATION BASE COUPLED WITH RISING BURDEN OF BREAST CANCER TO DRIVE MARKET GROWTH 30
FIGURE 13 MULTIMODALITY MAMMOGRAPHY WORKSTATIONS SEGMENT TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD 31
FIGURE 14 DIAGNOSTIC SCREENING SEGMENT IS ESTIMATED TO HOLD THE LARGEST SHARE OF THE MARKET IN 2019 32
FIGURE 15 HOSPITALS, SURGICAL CLINICS, AND DIAGNOSTIC IMAGING CENTERS SEGMENT TO HOLD THE LARGEST MARKET SHARE IN 2019 33
FIGURE 16 GERMANY IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD 34
FIGURE 17 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 18 MULTIMODALITY WORKSTATIONS TO ACCOUNT FOR A LARGER MARKET
SHARE IN 2018 43
FIGURE 19 DIAGNOSTIC SCREENING TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES AMONG ALL APPLICATIONS DURING THE FORECAST PERIOD 48
FIGURE 20 HOSPITALS, SURGICAL CLINICS, & DIAGNOSTIC IMAGING CENTERS ARE THE MAJOR END USERS IN THE EUROPE 54
FIGURE 21 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018 73
FIGURE 22 KEY DEVELOPMENTS IN THE EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, 2015–2019 74
FIGURE 23 GENERAL ELECTRIC HELD THE LEADING POSITION IN THE EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET AS OF 2017 76
FIGURE 24 AGFA GEVAERT GROUP: COMPANY SNAPSHOT (2017) 78
FIGURE 25 BARCO NV: COMPANY SNAPSHOT (2017) 81
FIGURE 26 ONEX: COMPANY SNAPSHOT (2017) 84
FIGURE 27 EIZO CORPORATION: COMPANY SNAPSHOT (2018) 86
FIGURE 28 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2017) 89
FIGURE 29 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2018) 91
FIGURE 30 HOLOGIC: COMPANY SNAPSHOT (2017) 93
FIGURE 31 KONINKLIJKE PHILIPS N.V.: COMPANY GLOBAL SNAPSHOT (2017) 95
FIGURE 32 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2017) 97
FIGURE 33 SECTRA AB: COMPANY SNAPSHOT (2017) 100
FIGURE 34 SIEMENS AG: COMPANY SNAPSHOT (2018) 102

 

List of Tables



TABLE 1 COUNTRIES WITH THE HIGHEST INCIDENCE OF BREAST CANCER IN EUROPE, 2018 36
TABLE 2 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 2017–2024 (USD MILLION) 42
TABLE 3 EUROPEAN MULTIMODALITY MAMMOGRAPHY WORKSTATIONS MARKET BY COUNTRY, 2017–2024 (USD MILLION) 44
TABLE 4 EUROPEAN MAMMOGRAPHY (X-RAY) WORKSTATIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 45
TABLE 5 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 2017–2024 (USD MILLION) 47
TABLE 6 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET FOR DIAGNOSTIC SCREENING, BY COUNTRY, 2017–2024 (USD MILLION) 49
TABLE 7 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET FOR ADVANCED IMAGING, BY COUNTRY, 2017–2024 (USD MILLION) 50
TABLE 8 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET FOR CLINICAL REVIEW BY COUNTRY, 2017–2024 (USD MILLION) 51
TABLE 9 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 2017–2024 (USD MILLION) 53
TABLE 10 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET FOR HOSPITALS, SURGICAL CLINICS, & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY 2017–2024 (USD MILLION) 55
TABLE 11 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET FOR BREAST CARE CENTERS, BY COUNTRY, 2017–2024 (USD MILLION) 56
TABLE 12 EUROPEAN MAMMOGRAPHY WORKSTATIONS MARKET FOR RESEARCHERS & ACADEMIA, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 13 EUROPE: MAMMOGRAPHY WORKSTATIONS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 59
TABLE 14 GERMANY: MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 2017–2024 (USD MILLION) 60
TABLE 15 GERMANY: MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 2017–2024 (USD MILLION) 61
TABLE 16 GERMANY: MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 2017–2024 (USD MILLION) 61
TABLE 17 UK: MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 2017–2024 (USD MILLION) 62
TABLE 18 UK: MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 2017–2024 (USD MILLION) 63
TABLE 19 UK: MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 2017–2024 (USD MILLION) 63
TABLE 20 FRANCE: MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 2017–2024 (USD MILLION) 64
TABLE 21 FRANCE: MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 2017–2024 (USD MILLION) 65
TABLE 22 FRANCE: MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 2017–2024 (USD MILLION) 65
TABLE 23 ITALY: MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 2017–2024 (USD MILLION) 66
TABLE 24 ITALY: MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 2017–2024 (USD MILLION) 67
TABLE 25 ITALY: MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 2017–2024 (USD MILLION) 67
TABLE 26 SPAIN: MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 2017–2024 (USD MILLION) 68
TABLE 27 SPAIN: MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 2017–2024 (USD MILLION) 69
TABLE 28 SPAIN: MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 2017–2024 (USD MILLION) 69
TABLE 29 ROE: MAMMOGRAPHY WORKSTATIONS MARKET, BY MODALITY 2017–2024 (USD MILLION) 70
TABLE 30 ROE: MAMMOGRAPHY WORKSTATIONS MARKET, BY APPLICATION 2017–2024 (USD MILLION) 71
TABLE 31 ROE: MAMMOGRAPHY WORKSTATIONS MARKET, BY END USER 2017–2024 (USD MILLION) 71
TABLE 32 NEW PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 75
TABLE 33 AGREEMENTS, PARTNERSHIPS, AND CONTRACTS 75